We studied 17 consecutive patients of Dengue Haemorrhagic Fever/Dengue
Shock Syndrome (DHF/DSS) to assess cardiac function by radionuclide v
entriculography, echocardiography and electrocardiography (ECG) during
the epidemic of Dengue virus type-2 (DEN-2) in Delhi, India (1996). C
ase definitions laid down by the WHO were followed. Fourteen patients
were seropositive for Dengue infection. In radionuclide ventriculograp
hy study, the mean left-ventricular ejection fraction was 41.69 (5.04%
(range 33-49%) and 7 patients had an ejection fraction less than 40%,
global hypokinesia was detected in 12 (70.59%) patients. In echocardi
ography, the mean ejection fraction was 47.06 (3.8%). Eight patients h
ad Dengue Shock Syndrome and the mean ejection fraction was 39.63% (4.
97% in radionuclide ventriculography, out of which 5 patients had an e
jection fraction below 40%. To find out the nature of myocardial invol
vement, 99m Tc-pyrophosphate imaging was done in 4 patients and it was
discontinued further because no myocardial necrosis was detected in t
hose patients. Five patients had ST and T changes in the electrocardio
gram, radionuclide ventriculography and echocardiography revealed no a
bnormalities after 3 weeks of follow up and the ejection fraction was
more than 50% in all cases. Global hypokinesia also improved and ECG c
hanges reverted back to normal within 3 weeks. Acute reversible cardia
c insult may be noticed in Dengue Haemorrhagic Fever/Dengue Shock Synd
rome and could be responsible for hypotension/shock seen in some of th
ese patients. Further studies are required to establish the pathogenic
mechanisms of cardiac dysfunction in patients with Dengue Haemorrhagi
c Fever/Dengue Shock Syndrome. (C) 1998 Elsevier Science Ireland Ltd.